Marker Therapeutics, Inc. (MRKR)
1.34
+0.02
(+1.52%)
USD |
NASDAQ |
Mar 20, 16:00
1.33
-0.01
(-0.75%)
After-Hours: 20:00
Marker Therapeutics Enterprise Value : 5.299M for March 20, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viridian Therapeutics, Inc. | 2.066B |
| ACADIA Pharmaceuticals, Inc. | 2.769B |
| Kiniksa Pharmaceuticals International Plc | 3.122B |
| electroCore, Inc. | 47.77M |
| Agenus, Inc. | 467.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.703M |
| Revenue (Quarterly) | 1.103M |
| Total Expenses (Quarterly) | 2.807M |
| EPS Diluted (Quarterly) | -0.1022 |
| Profit Margin (Quarterly) | -154.4% |
| Earnings Yield | -67.87% |
| Normalized Earnings Yield | -67.87 |